CARA

Q: What is the price of Cara Therapeutics (CARA) today?

The price of Cara Therapeutics (CARA) today is $ 0.00, with return of 0% compared to the last year. The price of Cara Therapeutics (CARA) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Cara Therapeutics (CARA) and international markets.

Q: When does Cara Therapeutics (CARA) pay dividends?

Cara Therapeutics (CARA) did not distribute dividends in the last year.

Q: Is Cara Therapeutics (CARA) worth it?

Currently, Cara Therapeutics (CARA) is priced at $ 0.00, with a P/E of -0.38%, representing a deviation of -2,845% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Cara Therapeutics (CARA) stock?

Investing in stocks of Cara Therapeutics (CARA) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Cara Therapeutics (CARA) yield today?

The yield of Cara Therapeutics (CARA) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Cara Therapeutics (CARA) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Cara Therapeutics Inc.

Price

$ -

return (12m)

0.00%

p/e

-0.38

p/bv

-5.80

DIVIDEND YIELD

0.00%

CARA price

CARA

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment CARA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals CARA

review the fundamentals of Cara Therapeutics shares

P/E

-0.38

Sector: -4.36 Industry: -13.38

P/S (PSR)

3.73

Sector: 1.79 Industry: 2.90

P/BV

-5.80

Sector: 2.09 Industry: 1.79

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-161.72%

Sector: -30.33% Industry: -67.81%

ROE

1,544.23%

Sector: -39.83% Industry: -59.34%

ROIC

-421.66%

Sector: -418.66% Industry: -484.72%

NET MARGIN

-100.00%

Sector: -32.52% Industry: -43.03%

GROSS MARGIN

91.32%

Sector: 42.44% Industry: 41.46%

OPERATING MARGIN

-100.00%

Sector: -27.49% Industry: -38.68%

EV/EBITDA

-0.42

Sector: -2.68 Industry: -9.74

EV/EBIT

-0.42

Sector: -3.96 Industry: -11.20

PRICE-TO-ASSETS

0.61

Sector: 1.06 Industry: 1.14

BVPS

-0.92

Sector: 3.44 Industry: 1.62

EPS

-14.18

Sector: -1.07 Industry: -1.89

EQUITY-TO-ASSETS RATIO

-0.10

Sector: 0.39 Industry: 0.32

LIABILITIES / ASSETS

1.10

Sector: 0.45 Industry: 0.36

CAGR REVENUE 5 YEARS

20.79%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-4.33%

Sector: - Industry: -

Fundamentals CARA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.57	35.11	86.53%	0.67%	$ 837.34 B	31.66%
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
SNY	12.82	1.39	10.86%	4.62%	$ 116.90 B	18.68%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
GSK	14.82	5.29	35.71%	2.96%	$ 113.04 B	17.48%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
IDXX	43.01	28.38	65.99%	0.00%	$ 45.56 B	24.62%
RMD	22.02	5.18	23.51%	1.04%	$ 32.72 B	27.53%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

CARA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Cara Therapeutics

Cara Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

22 years

Founded: 2004

2014

Time since IPO - 12 years

80

Employees

The Company Cara Therapeutics Inc. (United States), is listed on Nasdaq with a market value of $ 26.60 Millions, having an equity of $ -4.59 Millions.

With a total of 80 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 7.14 Millions, which generated a loss in the amount of $ -70.88 Millions.

As for its main indicators, the Company has a P/E ratio of -0.38, a P/BV ratio of -5.80 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker CARA.

Market cap

$ 26.60 Millions

Net worth

$ -4.59 Millions

US$ -4,590,000.00

Assets

$ 43.83 Millions

US$ 43,830,000.00

Total Shares Outstanding

5.00 Millions

5,000,000

Average Daily Trading Volume

$ 21.89 Thousand

US$ 21,889.56

Sector

Health

Industry

Pharmaceutical Products

CARA

CARA revenue and profits

Financial Results CARA

DRAG THE FRAME TO SEE MORE DATA

CARA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 73.49 20,94% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 270.02 --14,47% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 35.11 --43,31% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 177.83 --28,58% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 471.84 43,24% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 935.58 30,21% (12M)

P/E

40.57

0.67%

ROE

86.53%

P/BV

35.11

NVS - Novartis

$ 154.03 53,71% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34